Drug recall · August 6, 2025
Lorazepam Injection recall
Why: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
- Lots / codes
Lot # K24118, exp. date 10/31/2026
- Quantity
- 382,775 1mL vials
- Company
- Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- July 22, 2025 · Voluntary: Firm initiated
- Classified
- July 31, 2025
- Reported
- August 6, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lorazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.